COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 805: Articles 8041-8050  | Next

A New Paper Framework to Increase Reproducibility: Example Relating to Web Pharmacovigilance During COVID-19 in Italy
Rovetta, A., Castaldo, L.
10.1101/2022.05.03.22274607 — Posted: 2022-05-10
Adenovirus-Vectored SARS-CoV-2 Vaccine Expressing S1-N Fusion Protein
Khan, M. S., Kim, E., McPherson, A., Weisel, F. J., Huang, S., Kenniston, T. W., Percivalle, E., Gambotto, A., Baldanti, F., Meisel, M.
10.1101/2022.05.09.491179 — Posted: 2022-05-10
Inferring selection effects in SARS-CoV-2 with Bayesian Viral Allele Selection
Jankowiak, M., Obermeyer, F. H., Lemieux, J.
10.1101/2022.05.07.490748 — Posted: 2022-05-10
SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity
Meng, B., Datir, R., Choi, J., CITIID-NIHR BioResource COVID-19 Collaboration, , Bradley, J., Smith, K. G., Lee, J. H., Gupta, R. K.
10.1101/2022.05.07.491004 — Posted: 2022-05-10
Persistent serum protein signatures define an inflammatory subset of long COVID
Talla, A., Vasaikar, S. V., Szeto, G., Lemos, M. P., Czartoski, J. L., MacMillan, H., Moodie, Z., Cohen, K. W., Fleming, L. B., Thomson, Z., Okada, L., Becker, L. A., Coffey, E. M., DeRosa, S. C., Newell, E. W., Skene, P. J., Li, X., Bumol, T. F., McElrath, M. J., Torgerson, T. R.
10.1101/2022.05.09.491196 — Posted: 2022-05-10
Routine Saliva Testing for SARS-CoV-2 in Children: Partnering with Childcare Centers in the Greater New Haven Community
Rayack, E., Askari, H. M., Zirinsky, E., Lapidus, S., Sheikha, H., Peno, C., Kazemi, Y., Yolda-Carr, D., Liu, C., Grubaugh, N. D., Ko, A. I., Wyllie, A. L., Spatz, E. S., Oliveira, C. R., Bei, A. K.
10.1101/2022.05.05.22274434 — Posted: 2022-05-09
Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: a Retrospective Study
Boeder, S., Kobayashi, E., Ramesh, G., Serences, B., Kulasa, K., Majithia, A. R.
10.1101/2022.05.06.22274685 — Posted: 2022-05-09
Measuring the impact of nonpharmaceutical interventions on the SARS-CoV-2 pandemic at a city level: An agent-based computational modeling study of the City of Natal.
Lopes, P. H., Wellacott, L., de Almeida, L., Villavicencio, L. M. M., Moreira, A. L. d. L., de Sousa, R. K. R., Silva, P. d. S., Lima, L., Lones, M. A., do Nascimento, J.-D., Vargas, P. A., Moioli, R. C., Blanco Figuerola, W., Renno-Costa, C.
10.1101/2022.05.05.22274749 — Posted: 2022-05-09
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Vaccinated and Unvaccinated Patients in Mexico City
Hernandez-Teran, A., GarciaDiego, P., Villanueva-Reza, M., Boukadida, C., Taboada, B., Porras, E., Ahumada-Topete, V., Tapia Diaz, K., Matias-Florentino, M., Perez-Garcia, M., Avila-Rios, S., Mejia-Nepomuceno, F., Serna-Munoz, R., Juarez-Hernandez, F., Jimenez-Corona, M. E., Becerril-Vargas, E., Barreto, O., Martinez-Orozco, J. A., Perez-Padilla, R., Arias, C. F., Vazquez-Perez, J. A.
10.1101/2022.05.06.22274772 — Posted: 2022-05-09
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern
Mazzaferri, F., Mirandola, M., Savoldi, A., De Nardo, P., Morra, M., Tebon, M., Armellini, M., De Luca, G., Calandrino, L., Sasset, L., D'Elia, D., Sozio, E., Danese, E., Gibellini, D., Monne, I., Scroccaro, G., Magrini, N., Cattelan, A., Tascini, C., MANTICO Working Group, , Tacconelli, E.
10.1101/2022.05.06.22274613 — Posted: 2022-05-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).